Jazz Pharmaceuticals (JAZZ) PT Raised to $225 at Barclays
Tweet
Share
E-mailGet Alerts JAZZ Hot Sheet
Price: $244.96 --0%
Rating Summary:
33 Buy, 5 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 6 | Down: 4 | New: 9
Rating Summary:
33 Buy, 5 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 6 | Down: 4 | New: 9
Join SI Premium – FREE
Barclays analyst Balaji Prasad raised the price target on Jazz Pharmaceuticals (NASDAQ: JAZZ) to $225.00 (from $205.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Berenberg Upgrades Accelleron Industries AG (ACLN:SW) to Buy
- KBC Group (KBC:BB) (KBCSY) PT Raised to EUR117 at Barclays
- Nordic Semiconductor ASA (NOD:NO) PT Raised to NOK180 at Barclays
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
